cobalt has been researched along with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boison, D; Chen, QY; Fang, F; Feng, CJ; Gao, J; Huang, T; Ji, L; Kong, MY; Li, CH; Shao, J; Xu, XL | 1 |
| Chakravarty, AR; Jana, A; Kondaiah, P; Kundu, P; Paul, S | 1 |
2 other study(ies) available for cobalt and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
| Article | Year |
|---|---|
A Mn(II) complex of boradiazaindacene (BODIPY) loaded graphene oxide as both LED light and H2O2 enhanced anticancer agent.
Topics: Antineoplastic Agents; Boron Compounds; Cobalt; Drug Screening Assays, Antitumor; Graphite; Hep G2 Cells; Humans; Hydrogen Peroxide; Light | 2016 |
Cobalt(III) Complexes for Light-Activated Delivery of Acetylacetonate-BODIPY, Cellular Imaging, and Photodynamic Therapy.
Topics: Antineoplastic Agents; Boron Compounds; Cobalt; Dimethyl Sulfoxide; Hydroxybutyrates; Ligands; Pentanones; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2022 |